Resolute

Resolute Investment Managers and Ninety One Enter Strategic Partnership

Retrieved on: 
Tuesday, February 13, 2024
Asset Management, Professional Services, Finance, Head, Record, Investment, SMA, Resolute, Distribution, Partnership

Resolute Investment Managers, Inc. (“Resolute” or the “Company”), a diversified, multi-affiliate asset management platform with more than 30 affiliated and independent relationships, announced today that it has entered into a strategic partnership with global asset manager Ninety One North America, Inc. (“Ninety One”).

Key Points: 
  • Resolute Investment Managers, Inc. (“Resolute” or the “Company”), a diversified, multi-affiliate asset management platform with more than 30 affiliated and independent relationships, announced today that it has entered into a strategic partnership with global asset manager Ninety One North America, Inc. (“Ninety One”).
  • As a result of the new agreement, Resolute will be responsible for distributing two Ninety One separately managed account (“SMA”) strategies across its established distribution network of wealth management relationships.
  • The deployment of the Ninety One Global and International Franchise SMA strategies will help strengthen Resolute’s capabilities while further diversifying the Company’s product offerings.
  • Both of Ninety One’s SMA strategies aim to create meaningful participation in up markets, smaller drawdowns in down markets and lower-than-average volatility.

Two Time Breeder Cup Champ Goodnight Olive to Retire with Plans to Breed to Not This Time

Retrieved on: 
Tuesday, February 6, 2024
Eclipse, Partnership, Pedigree, New Amsterdam Theatre, News, Athlete, Mark, Breeders' Cup, Resolute, Taylormade, Pele (deity), Breeding, Puca, Shadwell Racing, Acquisition, Caravel, Breeder, Sale, Horse

MIDWAY, Ky., Feb. 6, 2024 /PRNewswire/ -- Resolute Farm today announced that Goodnight Olive, a remarkable sprint racing champion, will be retiring.

Key Points: 
  • MIDWAY, Ky., Feb. 6, 2024 /PRNewswire/ -- Resolute Farm today announced that Goodnight Olive, a remarkable sprint racing champion, will be retiring.
  • During her time on the track, Olive showcased her exceptional talent by earning over $2 million in just 12 races.
  • He said, "We purchased Olive at Fasig Tipton as a broodmare prospect and had hoped to continue her racing career.
  • However, recognizing the high-performance demands on these exceptional athletes, the decision to retire Olive was made to ensure her well-being.

Kudelski Security Expands Next-Generation Managed Detection & Response (MDR) Service, MDR ONE Resolute

Retrieved on: 
Tuesday, December 26, 2023
Intelligence, Cheseaux, MDR, ROI, Express, Anomaly, Hand, XDR, Benchmarking, Senior, Behavior, Kudelski Group, AI, Resolute, Risk, Digital forensics, SIEM, Partnership, Investment, Organization, SOAR, Client portal, Risk management

Managed Detection & Response (MDR) Service, MDR ONE Resolute

Key Points: 
  • Managed Detection & Response (MDR) Service, MDR ONE Resolute
    Cheseaux-sur-Lausanne, Switzerland, and Phoenix (AZ), USA – December 4, 2023 – Kudelski Security , the cybersecurity division within the Kudelski Group (SIX:KUD.S), today announced the launch of its expanded next-generation Managed Detection and Response (MDR) service, MDR ONE Resolute .
  • “Today, managed security providers are working around the clock to keep ahead of increasingly sophisticated attacks, accelerated by AI and an increasingly complex threat management challenge,” said Jacques Boschung, Head of  Kudelski Security.
  • As a turnkey solution, MDR ONE Resolute integrates with the client’s existing technology and eliminates the need for costly SIEM investments.
  • “This next-gen MDR service extends our detection and response capabilities in a lean way,” said Christophe Nicolas, Senior Vice President and Group CIO, Kudelski Group.

Resolute Investment Managers Honored With Pensions & Investments’ Best Places to Work In Money Management Award for Fifth Consecutive Year

Retrieved on: 
Monday, December 11, 2023
Finance, Banking, Professional Services, Asset Management, Human Resources, Research, The Last Best Place, Pension, Communication, Resolute, Growth, P&I, News, Crain Communications, Philosophy, Financial adviser, Management, Investment

Resolute Investment Managers, Inc. (“Resolute”), a diversified, multi-affiliate asset management platform with more than 30 affiliated and independent relationships, is one of the distinguished honorees in the 2023 Best Places to Work in Money Management awards announced today by Pensions & Investments.

Key Points: 
  • Resolute Investment Managers, Inc. (“Resolute”), a diversified, multi-affiliate asset management platform with more than 30 affiliated and independent relationships, is one of the distinguished honorees in the 2023 Best Places to Work in Money Management awards announced today by Pensions & Investments.
  • This marks the fifth consecutive year Resolute has been honored with the award.
  • “It truly is an honor for Resolute to be recognized for this award for the fifth consecutive year.
  • For a complete list of the 2023 Pensions & Investments’ Best Places to Work in Money Management winners and profiles of the top 100 firms across size categories, go to www.pionline.com/BPTW2023 .

Elixir Medical Completes Submission of DynamX Coronary Bioadaptor System to Japan’s PMDA Agency for Regulatory Approval

Retrieved on: 
Wednesday, October 4, 2023
Surgery, Medical Devices, Health, Clinical Trials, Cardiology, Elixir, Percutaneous coronary intervention, Medicine, Plaque, AC 25.1309-1, BRS, CAD, Pharmaceuticals and Medical Devices Agency, Catheter, TLF, PCI, Resolute, Motion, Catheterization laboratory, Standard of care, Patient, Physician, PMDA, Division, Randomized controlled trial, Stent, Coronary artery disease, Pharmaceutical industry

Elixir Medical , a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the approval of the DynamX® Coronary Bioadaptor System for the treatment of coronary artery disease (CAD).

Key Points: 
  • Elixir Medical , a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the approval of the DynamX® Coronary Bioadaptor System for the treatment of coronary artery disease (CAD).
  • DynamX coronary bioadaptor was developed to overcome the limitations of drug-eluting stents (DES) and bioresorbable scaffolds (BRS).
  • “Our submission for approval in Japan is an exciting milestone for the company and industry.
  • The DynamX coronary bioadaptor represents a culmination of major design and manufacturing breakthroughs and three clinical trials consistently demonstrating differentiated functional performance compared to the standard of care,” said Motasim Sirhan, CEO of Elixir Medical.

Bringing home those who gave the last full measure of devotion

Retrieved on: 
Tuesday, September 5, 2023
Billy Frank Jr. Nisqually National Wildlife Refuge, Military personnel, Mount Rainier National Park, Curtiss C-46 Commando, Weather, Resolute, Indigenous peoples, Climate change, Research, Friends, Aluminium, Tunnel

The airplane, carrying thirty-two military personnel, was flying from San Diego to Seattle when it encountered extreme weather conditions.

Key Points: 
  • The airplane, carrying thirty-two military personnel, was flying from San Diego to Seattle when it encountered extreme weather conditions.
  • The Resolute Promise team plans to continue surveying the glacier utilizing advanced technologies, including optical and satellite imagery.
  • Considering climate change and the availability of modern technology, the Resolute Promise team believes the site can be more clearly understood.
  • Resolute Promise would like to hear from family members, loved ones, and friends of those who were lost that fateful day.

Elixir Medical Completes Enrollment of INFINITY-SWEDEHEART Clinical Trial

Retrieved on: 
Thursday, July 13, 2023
Cardiology, Biotechnology, Pharmaceutical, Surgery, General Health, Health, Clinical Trials, Other Health, Elixir, Lund University, Moyamoya disease, Percutaneous coronary intervention, Medicine, Plaque, Myocardial infarction, CAD, TLF, PCI, Resolute, Patient, Angina, Stent, Coronary artery disease, Uppsala University Hospital, Safety, Pharmaceutical industry

Elixir Medical , a developer of breakthrough cardiovascular technologies, today announced enrollment completion in INFINITY-SWEDEHEART, a prospective, multicenter, single-blind, randomized clinical trial of the DynamX® Coronary Bioadaptor System, the first metallic coronary artery implant that adapts to vessel physiology versus the Resolute Onyx™ Drug-Eluting Stent (DES).

Key Points: 
  • Elixir Medical , a developer of breakthrough cardiovascular technologies, today announced enrollment completion in INFINITY-SWEDEHEART, a prospective, multicenter, single-blind, randomized clinical trial of the DynamX® Coronary Bioadaptor System, the first metallic coronary artery implant that adapts to vessel physiology versus the Resolute Onyx™ Drug-Eluting Stent (DES).
  • The primary Device Oriented Clinical Endpoint is target lesion failure (TLF); a composite of cardiovascular death, target vessel myocardial infarction (TV-MI), and ischemia-driven target lesion revascularization (ID-TLR).
  • “We are thrilled to complete enrollment of INFINITY-SWEDEHEART as we continue building a world-class body of clinical evidence that supports the DynamX Bioadaptor as the best treatment for patients living with coronary artery disease (CAD),” said Motasim Sirhan, CEO of Elixir Medical.
  • We look forward to assessing the bioadaptor data coming out of INFINITY-SWEDEHEART with this large, real-world patient population.”
    INFINITY-SWEDEHEART is the fourth trial of Elixir Medical’s robust DynamX Bioadaptor clinical evidence program consisting of nine company-sponsored and investigator-initiated studies enrolling more than 9,000 patients.

Resolute Announces Ratification of Collective Agreement Covering Quebec Woodlands Operations

Retrieved on: 
Friday, June 2, 2023
Saint Thomas, Comtois horse, Girardville, Resolute, Mauricie, Management, Unifor

MONTRÉAL, June 2, 2023 /PRNewswire/ - Resolute Forest Products Inc. today announced the ratification of a four-year master labor agreement with the Unifor union covering 525 hourly employees at ten company woodlands in Quebec, following an agreement-in-principle reached on May 11.

Key Points: 
  • MONTRÉAL, June 2, 2023 /PRNewswire/ - Resolute Forest Products Inc. today announced the ratification of a four-year master labor agreement with the Unifor union covering 525 hourly employees at ten company woodlands in Quebec, following an agreement-in-principle reached on May 11.
  • "We are pleased to renew this agreement, which underscores the contribution of our woodlands employees to the company's success and provides stability for our customers, communities and other partners," said Remi G. Lalonde, president and chief executive officer.
  • The individual collective agreements ratified on May 26 cover Resolute's Abitibi and Nord-du-Québec (Comtois, Senneterre), Côte-Nord, Lac-Saint-Jean (Girardville, La Doré, Mistassini, Péribonka, Saint-Félicien, Saint-Thomas) and Mauricie woodlands operations.

Performance Biofilaments Inc. Announces Start-Up of Nanofibrillated Cellulose Commercial Production

Retrieved on: 
Wednesday, May 17, 2023
Forest product, NFC, Cellulose, Resolute, Resolute Forest Products, Carbon, Forest, Performance

VANCOUVER, BC, May 17, 2023 /PRNewswire/ - Performance BioFilaments Inc. is pleased to announce the start-up of the world's largest nanofibrillated cellulose (NFC) commercial production plant at Resolute's Forest Products, Kénogami paper mill in Quebec.

Key Points: 
  • VANCOUVER, BC, May 17, 2023 /PRNewswire/ - Performance BioFilaments Inc. is pleased to announce the start-up of the world's largest nanofibrillated cellulose (NFC) commercial production plant at Resolute's Forest Products, Kénogami paper mill in Quebec.
  • Nanofibrillated cellulose is a natural, renewable and sustainable biomaterial derived from well-managed, certified forests.
  • "The Performance BioFilaments team and development partners have dedicated years of effort to bring this low-carbon biomaterial to market," said Gurminder Minhas, Managing Director of Performance BioFilaments.
  • "We have collaborated extensively across a range of industrial supply chains, integrating nanofibrillated cellulose to achieve cost, quality and dramatic performance improvements.

Performance Biofilaments Inc. Announces Start-Up of Nanofibrillated Cellulose Commercial Production

Retrieved on: 
Wednesday, May 17, 2023
Forest product, NFC, Cellulose, Resolute, Resolute Forest Products, Carbon, Forest, Performance

VANCOUVER, BC, May 17, 2023 /PRNewswire/ -- Performance BioFilaments Inc. is pleased to announce the start-up of the world's largest nanofibrillated cellulose (NFC) commercial production plant at Resolute's Forest Products, Kénogami paper mill in Quebec.

Key Points: 
  • VANCOUVER, BC, May 17, 2023 /PRNewswire/ -- Performance BioFilaments Inc. is pleased to announce the start-up of the world's largest nanofibrillated cellulose (NFC) commercial production plant at Resolute's Forest Products, Kénogami paper mill in Quebec.
  • Nanofibrillated cellulose is a natural, renewable and sustainable biomaterial derived from well-managed, certified forests.
  • "The Performance BioFilaments team and development partners have dedicated years of effort to bring this low-carbon biomaterial to market," said Gurminder Minhas, Managing Director of Performance BioFilaments.
  • "We have collaborated extensively across a range of industrial supply chains, integrating nanofibrillated cellulose to achieve cost, quality and dramatic performance improvements.